Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.9090
+0.0129 (1.44%)
Aug 29, 2025, 10:14 AM - Market open

Marker Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
123349237970
Upgrade
Market Cap Growth
-64.25%-31.89%115.29%-71.23%13.36%-47.12%
Upgrade
Enterprise Value
12431124255
Upgrade
Last Close Price
0.903.115.502.669.5014.50
Upgrade
PS Ratio
1.805.0514.776.4663.58149.18
Upgrade
PB Ratio
0.971.793.481.161.802.55
Upgrade
P/TBV Ratio
1.111.793.481.161.802.55
Upgrade
EV/Sales Ratio
0.213.699.493.5234.02117.63
Upgrade
Debt / Equity Ratio
----0.270.45
Upgrade
Asset Turnover
0.410.340.130.070.020.01
Upgrade
Quick Ratio
2.846.225.251.823.283.49
Upgrade
Current Ratio
3.456.365.572.143.563.81
Upgrade
Return on Equity (ROE)
-144.68%-65.81%-83.47%-62.20%-117.42%-80.37%
Upgrade
Return on Assets (ROA)
-69.38%-35.50%-35.36%-24.12%-43.38%-39.26%
Upgrade
Return on Capital (ROIC)
-90.86%-42.62%-54.16%-32.79%-51.70%-42.90%
Upgrade
Earnings Yield
-125.99%-32.23%-16.85%-131.80%-53.05%-41.22%
Upgrade
FCF Yield
-93.87%-32.76%-33.63%-118.78%-38.52%-42.06%
Upgrade
Buyback Yield / Dilution
-21.50%-1.94%-5.49%-9.16%-62.64%-3.19%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q